Literatur
- 1
ACCP consensus report .
Clinical indications for non invasive positive pressure ventilation in chronic respiratory
failure due to restrictive lung disease, COPD, and nocturnal hypoventilation. A consensus
conference report.
Chest.
1999;
116
521-534
- 2
Ambrosino N, Nava S, Bertone P, Fracchia C, Rampulla C.
Physiologic evaluation of pressure support ventilation by nasal mask in patients with
stable COPD.
Chest.
1992;
101
385-391
- 3
American Thoracic Society statement .
Standards for the diagnosis and care of patients with chronic obstructive pulmonary
disease.
Am J Respir Crit Care Med.
1995;
152
77-120
- 4
British Thoracic Society .
Guidelines for the management of COPD.
Thorax.
1997;
52
1-28
- 5
Calverley P MA, Brezinova V, Douglas N J. et al .
The effect of oxygenation on sleep quality in chronic bronchitis and emphysema.
Am Rev Respir Dis.
1982;
126
206-210
- 6
Casanova C, Celli B R, Tost L. et al .
Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients
with severe COPD.
Chest.
2000;
118
1552-1590
- 7
Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu J M.
Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical
ventilation. A 10-year analysis of ANTADIR observatory.
Chest.
1996;
109
741-749
- 8
Chaouat A, Weitzenblum E, Kessler R. et al .
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease
patients.
Eur Respir J.
1999;
14
1002-1008
- 9
Chaouat A, Weitzenblum E, Kessler R. et al .
Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related
oxygen desaturation.
Eur Respir J.
2001;
17
848-855
- 10
Clini E, Sturani C, Rossi A. et al .
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary
disease patients.
Eur Resp J.
2002;
20
529-538
- 11
Cooper C B.
Life expectancy in severe COPD.
Chest.
1994;
105
335-337
- 12
Dean N C, Brown J K, Himelman R B. et al .
Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary
disease and only mild hypoxemia.
Am Rev Respir Dis.
1992;
146
941-945
- 13
Deutsche Gesellschaft für Pneumologie .
Leitlinien zur Langzeit-Sauerstofftherapie.
Pneumologie.
2001;
55
454-464
- 14
Dubois P, Jamart J, Machiels J, Smeets F, Lulling J.
Prognosis of severely hypoxemic patients receiving long-term oxygen therapy.
Chest.
1994;
105
469-474
- 15
Eaton T, Lewis C, Young P, Kennedy Y, Garrett J E, Kolbe J.
Long-term oxygen therapy improves health-related quality of life.
Respir Med.
2004;
98
285-293
- 16
Elliott M W, Mulvey D A, Moxham J, Green M, Branthwaite M A.
Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms
underlying changes in arterial blood gas tensions.
Eur Respir J.
1991;
4
1044-1052
- 17
ERS Consensus Statement .
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J.
1995;
8
1398-1420
- 18
Fleetham J, West P, Mezon B. et al .
Sleep, arousals and oxygen desaturation in chronic obstructive pulmonary disease:
the effect of oxygenation therapy.
Am Rev Respir Dis.
1982;
126
429-433
- 19
Fletcher E C, Donner C F, Midgren B. et al .
Survival in COPD patients with a daytime PaO2 > 60mmHg with and without nocturnal
oxyhemoglobin desaturation.
Chest.
1992;
101
649-655
- 20
Fletcher E C, Luckett R A, Goodnight-White S, Miller C C, Qian W, Costarangos-Galarza C.
A double-blind trial of nocturnal supplement oxygen for sleep desaturation in patients
with chronic obstructive pulmonary disease and a daytime PaO2 above 60mmHg.
Am Rev Respir Dis.
1992;
142
1070-1076
- 21
Fujimoto K, Matsuzawya Y, Yamaguchi S, Koizumi T, Kubo K.
Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients
with mild hypoxemia.
Chest.
2002;
122
457-463
- 22
Gay P C, Hubmayr R D, Stroetz R W.
Efficacy of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary
disease during a 3-month controlled trial.
Mayo Clin Proc.
1996;
71
533-542
- 23
Gillissen A, Buhl R, Kardos P. et al .
Management der akuten Exazerbation der chronisch-obstruktiven Lungenerkrankung (COPD).
Dtsch Med Wochenschr.
2003;
128
1721-1727
- 24
Gorecka D, Gorzelak K, Sliwinski P. et al .
Effect of long-term oxygen therapy on survival in patients with chronic obstructive
pulmonary disease with moderate hypoxemia.
Thorax.
1997;
52
674-679
- 25
Jolly E C, Di Boscio V, Aguirre L. et al .
Effects of supplemental oxygen during activity in patients with advanced COPD without
severe resting hypoxaemia.
Chest.
2001;
120
437-443
- 26
Kardos P.
Chronisch obstruktive Lungenerkrankung (COPD): Aktuelle Diagnostik und Therapie.
Dtsch Med Wochenschr.
2004;
129
490-493
- 27
Kessler R, Faller M, Weitzenblum E. et al .
Natural history of pulmonary hypertension in a series of 131 patients with chronic
obstructive lung disease.
Am J Respir Crit Care Med.
2001;
164
219-224
- 28
Leggett R JE, Flenley D C.
Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale.
Br Med J.
1977;
2
84-86
- 29
Lightowler J V, Wedzicha J A, Elliott M W, Ram F SF.
Non-invasive positive pressure ventilation to treat respiratory failure resulting
from exacerbations of chronic obstructive pulmonary disease: Cochrane systemativ review
and meta-analysis.
Brit Med J.
2003;
326
185-189
- 30
Lin C C.
Comparison between nocturnal nasal positive pressure ventilation combined with oxygen
therapy and oxygen monotherapy in patients with severe COPD.
Am J Respir Crit Care Med.
1996;
154
353-358
- 31
Medical Research Council Working Party .
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating
chronic bronchitis and emphysema.
Lancet.
1981;
1
681-686
- 32
Meecham-Jones D J, Paul E A, Jones P W, Wedzicha J A.
Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone
in hypercapnic COPD.
Am J Respir Crit Care Med.
1995;
152
538-544
- 33
Murray C JL, Lopez A D.
Alternative projections of mortality and disability by cause 1990 - 2020: Global Burden
of Disease Study.
Lancet.
1997;
349
1498-1504
- 34
Nava S, Fanfulla F, Frigerio P. et al .
Physiologic evaluation of 4 weeks of nocturnal nasal positive pressure ventilation
in stable hypercapnic patients with chronic obstructive pulmonary disease.
Respiration.
2001;
68
573-583
- 35
Nocturnal Oxygen Therapy Trial Group .
Continuous or nocurnal oxygen therapy in hypoxemic chronic obstructive lung disease.
Ann Intern Med.
1980;
93
391-398
- 36
Okubadejo A A, Paul E A, Jones P W, Wedzicha J A.
Does long-term oxygen therapy affect quality of life in patients with chronic obstructive
pulmonary disease and severe hypoxaemia?.
Eur Respir J.
1996;
9
2335-2339
- 37
Oswald-Mammosser M, Weitzenblum E, Quoix E. et al .
Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance
of pulmonary artery pressure.
Chest.
1995;
107
1193-1198
- 38
Pauwels R A, Bruist S A, Calverley P MA. et al .
Global strategy for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease.
Am J Respir Crit Care Med.
2001;
163
1256-1276
, update 2004: www.goldcopd.com
- 39
Plywaczewski R, Sliwinski P, Nowinski A, Kaminski D, Zielinski J.
Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing
long-term oxygen therapy.
Chest.
2000;
117
679-683
- 40
Renston J P, DiMarco A F, Supinski G S.
Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe
COPD.
Chest.
1994;
105
1053-1060
- 41
Schäfer H, Ewig S, Gillissen A.
Therapie der schweren Exazerbation bei chronisch obstruktiver Lungenerkrankung.
Intensivmed.
2000;
37
176-186
- 42
Schönhofer B, Kuhlen R.
Beatmung als Therapie der akuten respiratorischen Insuffizienz.
Dtsch Med Wochenschr.
2004;
129
517-522
- 43
Strumpf D A, Millmann R P, Carlisle C C. et al .
Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic
obstructive pulmonary disease.
Am Rev Respir Dis.
1991;
144
1234-1239
- 44
Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A.
Long-term oxygen therapy can reverse the progression of pulmonary hypertension in
patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1985;
131
493-498
- 45
Weitzenblum E, Chaouat A, Charpentier C. et al .
Sleep-related hypoxaemia in chronic obstructive pulmonary disease: causes, consequences
and treatment.
Respiration.
1997;
64
187-193
- 46
Wettengel R, Böhning W, Cegla U. et al .
Empfehlungen der Deutschen Atemwegsliga zur Behandlung von Patienten mit chronisch-obstruktiver
Bronchitis und Lungenemphysem.
Med Klin.
1995;
90
3-7
- 47
Wijkstra P J, Lacasse Y, Guyatt G H. et al .
A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients
with stable COPD.
Chest.
2003;
124
337-343
- 48
Worth H, Buhl R, Cegla U. et al .
Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie
zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und
Lungenemphysem (COPD).
Pneumologie.
2002;
56
704-738
- 49
Wright J L, Levy R D, Churg A.
Pulmonary hypertension in chronic obstructive pulmonary disease: current theories
of pathogenesis and their implications for treatment.
Thorax.
2005;
60
605-609
- 50
Zielinski J, Tobiasz M, Hawrylkiewicz I. et al .
Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a
6-year prospective study.
Chest.
1998;
113
65-70
Priv.-Doz. Dr. med. Harald Schäfer
Ltd. Arzt Pneumologie und Schlafmedizin, Medizinische Klinik II, Klinikum Saarbrücken
Winterberg 1
66119 Saarbrücken
Phone: 0681/9632434
Fax: 0681/9632378
Email: h.schaefer@klinikum-saarbruecken.de
